The next chapter of the right-wing war on the Affordable Care Act involves a case that targets the preventative care that ...

(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention ...

But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

The U.S. initiative to fight HIV globally, PEPFAR, is at a crossroad where it must focus on sustainable health systems and ...

The Supreme Court will hear a challenge to Obamacare’s preventive care mandates, giving Trump a chance to reshape rules on ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

A new report has shed light on the struggles of HIV-positive Palestinians living in Gaza, where medication is running out.

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and ...

The flagship U.S. aid program on HIV/AIDS is in jeopardy, a senior Republican warned on Thursday, after U.S. officials said four nurses in Mozambique performed abortions that are banned under the ...

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where ...